• Journal of Dairy Science and Biotechnology
• /
• 제41권3호
• /
• pp.113-125
• /
• 2023

In this study, we explored the synergistic effects of whey protein concentrate (WPC) and soybean protein components after fermentation with lactic acid bacteria isolated from kimchi, and identified several peptides with desirable physiological functions, proteolysis, and immune effects. Antioxidant activity was determined using 2,2'-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid, 1,1-diphenyl-2-picrylhydrazyl, ferric-reducing antioxidant power, and hydroxyl radical scavenging assays, followed by cross-validation of the four antioxidant activities. These assays revealed that samples with a 8:2 and 9:1 whey to soy ratio possessed higher antioxidant activity than the control samples. Antibacterial potency testing revealed high antibacterial activity in the 9:1 and 8:2 samples. Cytotoxicity testing of samples using 3-(4, 5-dimethyl thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide revealed that only the 10:0, 1:9, and 0:10 samples had <80% viable cells, indicating no significant cytotoxicity. Nitric oxide (NO) assays revealed that NO expression was reduced in 8:2, 5:5, and 0:10 protein ratio fermentations, indicating low inflammatory reaction stimulatory potential. Cytokine expression was confirmed using an enzyme-linked immunosorbent assay kit. The 8:2 sample had the lowest inflammatory cytokine (interleukin [IL]-1α, IL-6, and tumor necrosis factor-α) levels compared with the lipopolysaccharide-treated group. Amino acid profiling of the 8:2 sample identified 17 amino acids. These results suggest that inoculating and fermenting Lactobacillus plantarum DK203 and Lactobacillus paracasei DK209 with an 8:2 mixture of WPC and soybean protein releases bioactive peptides with excellent anti-inflammatory and antioxidant properties, making them suitable for functional food development.

• Korean Journal of Radiology
• /
• 제1권3호
• /
• pp.121-126
• /
• 2000

Objective: To evaluate the therapeutic efficacy of a new liquid embolic material, Embol, in embolization of the renal artery. Materials and Methods: Embol is a new embolic material obtained by partial hydrolysis of polyvinyl acetate mixed in absolute ethanol and Iopromide 370 and manufactured by Schering Korea, Kyonggido, Korea. Six patients who underwent embolization of the renal artery using Embol were evaluated. Four were male and two were female and their ages ranged from 11 to 70 (mean, 53) years. Clinical and radiologic diagnoses referred for renal artery embolization were renal cell carcinoma (n = 3), renal angiomyolipoma (n = 2) and pseudoaneurysm of the renal artery (n = 1). After selective renal angiography, Embol was injected through various catheters, either with or without a balloon occlusion catheter. Changes in symptoms and blood chemistry which may have been related to renal artery embolization with Embol were analyzed. Results: The six patients showed immediate total occlusion of their renal vascular lesions. One of the three in whom renal cell carcinoma was embolized with Embol underwent radical nephrectomy, and the specimen thus obtained revealed 40% tumor necrosis. In the two patients with angiomyolipomas, the tumors decreased in size and abdominal pain subsided. Bleeding from pseudoaneurysm of the renal artery was successfully controlled. Four patients showed symptoms of post-embolization syndrome, and one of these also showed increased levels of blood urea nitrogen and creatinine. One patient experienced transient hypertension. Conclusion: Embol is easy to use, its radiopacity is adequate and it is a safe and effective embolic material which provides immediate and total occlusion of renal vascular lesions.

• 한국간담췌외과학회지
• /
• 제27권2호
• /
• pp.141-150
• /
• 2023

Pancreatic carcinosarcoma is a very rare malignancy with a poor prognosis. Because of these characteristics, a treatment strategy for it has not been established yet. The aim of this study was to establish a therapeutic strategy for pancreatic carcinosarcoma. We reviewed data of a 65-year-old female patient who was diagnosed with pancreatic carcinosarcoma through endoscopic ultrasound-guided fine needle aspiration biopsy before surgery. For literature review, we searched PubMed using terms of "Pancreatic" or "Pancreas" and "carcinosarcoma" or "carcinosarcomatous". The patient received 11 cycles of neoadjuvant treatment with leucovorin, fluorouracil, irinotecan, oxaliplatin and pembrolizumab because the tumor was borderline resectable. She underwent stereotactic ablative body radiotherapy (SABR) with 35 Gy in 5 fractions, followed by robotic pylorus-preserving pancreaticoduodenectomy. After surgery, the patient received adjuvant chemotherapy in the same regimen as before surgery. She is alive without any recurrence. Among 48 patients within 33 available papers, the median survival time was 15 months. The survival rate of patients who received adjuvant chemotherapy tended to be higher than that of those who did not receive adjuvant chemotherapy, although the difference was not statistically significant (median survival, 47 vs. 15 months; p = 0.485). Three patients who received neoadjuvant chemotherapy had a survival period of 13-23.5 months. Surgery with lymphadenectomy, adjuvant therapy, and neoadjuvant therapy are thought to help improve survival outcomes. Modern treatment approaches for conventional pancreatic ductal adenocarcinoma could be applied to pancreatic carcinosarcoma.

• Radiation Oncology Journal
• /
• 제11권1호
• /
• pp.79-82
• /
• 1993

본 연구는 1989년 10월부터 1992년 3월까지 아산재단 서울중앙병원에서 원발성 중추신경계 림프종으로 진단 받은 10명의 환자를 대상으로 하였다. 병리적 진단을 위한 조직은 5명에서 개두술에 의한 종양절제술로 얻어졌으며 나머지는 정위적 조직생검에 의해 얻어졌다. 성별분포는 남녀가 각 5명이었고 연령분포는 28세부터 72세로 평균연령은 45세로 나타났다. Working Formulation에 의한 세포아형은 7명에서 diffuse large cell type이었고 3명은 diffuse mixed cell type이었다. 전산화 단층촬영 결과 6명은 단일병소로 나타났으며 4명은 다발성병소로 나타났다. 치료는 전 환자가 전뇌방사선 조사를 4000 cGy/20 fx을 받은 후 원발병소에 2000 cGy/10 fx을 조사하여 총 6000 cGy를 시행하였다. 척수액 검사상 양성인 6명은 전뇌조사와 척수강내 항암제 투여를 받았으며 그중 1명은 척수강내 항암제 투여 3회 실시후 척수방사선 조사를 받았다. 척수액 검사상 음성인 4명중 3명은 전뇌조사만 실시했고 나머지 1명은 방사선 조사전 전신 항암제 투여를 받았다. 추적관찰기간은 7개월에서 26개월이었으며 평균 추적기간은 8개월 이었다. 1년 생존율은 86%이었고 2년 생존율은 69%로 나타났다. 현재까지 2명이 척수강내 재발 후 뇌실질내 재발로 사망했으며, 반면 7명의 환자는 방사선 치료후 병소가 완전히 없어졌다. 위의 결과로 볼때 원발성 중추신경계 림프종의 방사선 치료에 대한 월등한 초기반응과 원격 전이 가 적은 것을 고려하여 원발병소에 분할치료 방법들을 통한 전체 조사량을 증가시키는 것이 효과적이라고 생각되며 척수액 검사상 양성인 경우는 척수 방사선 조사와 척수강내 항암제를 함께 쓰는 좀더 적극적 치료가 필요하리라 생각된다.

• Applied Microscopy
• /
• 제38권1호
• /
• pp.43-50
• /
• 2008

곡류, 두류, 과채류, 해조류, 버섯류 등의 식물성 원료를 가열처리하지 않은 상태에서 분말화한 것을 혼합한 생식의 성분 중 생리활성물질은 강력한 항산화 기능 및 일부 항암효과를 포함한 생리활성기능을 나타낸다. 본 실험은 BALB/c 마우스에 CT-28 대장암세포를 피하주사한 후 비타민 C와 생식을 급이함으로써 암조직의 증식에 따른 항암효과를 확인하기 위하여 수행하였다. 각 실험군은 CT-26 세포를 피하주사한 후 암조직의 크기를 5일 간격으로 6회 측정한 결과 비타민 C를 급이한 군은 암을 유도한 군과 암조직의 부피를 비교한 결과 통계학적으로 유의성은 없었으나 암세포 주입 후 10, 15, 20일째의 평균 암조직 부피에서 대조군은 각각 $155.8{\pm}75.8\;mm^3$, $238{\pm}102.9\;mm^3$, $525.0{\pm}291.7\;mm^3$인데 비해서 생식군은 48.1% ($80.8{\pm}60.0\;mm^3$), 43.2% ($135.2{\pm}117.2\;mm^3$), 55.5% ($233.6{\pm}248.2\;mm^3$)의 억제율을 보여주었다. 특히 25일과 30일째에는 대조군의 암조직 부피가 $989.7{\pm}596.8\;mm^3$와 $1589.7{\pm}1071.0\;mm^3$로 급격히 증가한 반면 생식군은 $304.6{\pm}442.5\;mm^3$와 $464.9{\pm}705.9\;mm^3$로 대조군에 비해 각각 69.2%와 70.7%의 감소율을 보임으로써 암조직의 증식이 현저히 억제된 결과를 보여주었다. 특히 30일째 암조직의 차이는 통계학적으로도 유의한 차이를 나타내었다(p<0.05). 따라서 생식은 CT-26 결장암 세포주에 의해 유도된 암증식을 억제하는 효과가 있는 것으로 생각된다.

• Investigative Magnetic Resonance Imaging
• /
• 제8권1호
• /
• pp.32-41
• /
• 2004

목적 : MnPC의 자기이완성질을 살펴보고, 토끼의 간에 이식한 VX2 암종을 이용해 자기공명영상에서 간의 조영증강형태를 관찰하고자하였다. 또한 간세포 특이성 조영제 사용 시와 비교하여 MnPC의 조직특이성 조영제로서의 가능성을 탐색해 보고자 하였다. 대상 및 방법 : 조영제 합성시 상자성 원소의 배위자로 phthalocyanine(PC)를 선택하였다. 2.01 g (5.2 mmol)의 phthalocyanine을 0.37g(1.4 mmol)의 manganese chloride와 $310^{\circ}C$에서 36시간동안 반응시킨 후 혼합물을 크로마토그래피 (CHC13: CH3OH=98:2, volume ratio)로 정제하여 2000 달톤의 분자량을 갖는 1.04 g $(46\%)$의 MnPC를 얻었다. 자기이완율은 MnPC를 0.1 mmol로 희석시켜 1.5 T (64 MHz)에서 측정하였다. VX2 암종은 토끼의 간실질 내에 종양세포 부유액을 주입해 실험적으로 유발시켰다. 모든 영상은 1.5 T MR장비에서 무릎관절코일을 사용하여 획득하였다. 본 연구에서 새로 개발된 거대분자 자기공명영상 조영제인 MnPC (4m-mol/kg)와 간세포 특이성 조영제인 Mn-DPDP (0.01 mmol/kg)가 사용되었으며 이들 조영제는 토끼의 이정맥을 통해 주입되었다. T1 강조영상은 스핀에코 (TR/TE=516/14 msec)와 고속다면회손경사회복 (TR/TE=80/4 m-sec, flip angle $60^{\circ}$)을 사용하여 얻었고, T2 강조영상의 획득을 위해서는 고속스핀에코 (TR/TE=1200/85 m-sec)를 사용하였다. 결과 MnPC의 1.5T (64MHz)에서의 자기이완율은 $R1=7.28\;mM^{-1}S^{-1}$, $R2=55.56\;mM^{-1}S^{-1}$ 이었고, MnPC의 높은 T2 자기이완율은 T2 강조영상에서의 정상 간실질의 신호강도를 감소시켜 간실질과 VX2 암종의 구분을 쉽게 하였다. MnPC 주입시 T1 강조영상에서는 간세포 특이성 조영제의 주입시보다 종양의 경계가 명확하였고, 조영증강은 주입후 최소한시간 이상 높게 유지되었다. 결론 : MnPC가 간세포로 흡수되어 담관으로 배설된다는 사실은 Mn-DPDP와 유사한 특성이며 이는 MnPC가 새로운 간특이성 조영제임을 확인시켜 준다. 또한 MnPC의 R2값이 기존의 조영제에 비해 매우 크다는 사실은 T1 조영제로서 뿐만 아니라 T2 조영제로서의 사용 가능성을 보여준다. 이러한 사실들을 좀더 정확하게 뒷받침하기 위해서는 임상적으로 사용되기 이전에 생체 내 그리고 시험관내 연구가 더 필요하며 다른 동물모델에서의 추가적인 연구가 요구된다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권6호
• /
• pp.3647-3652
• /
• 2013

Purpose: To evaluate the diagnostic value of $^{18}F$-FDG PET/CT for detection of bone metastasis in comparison with the efficacies of $^{18}F$-FDG PET/CT, CT, $^{18}F$-FDG PET and conventional planar bone scintigraphy in a series of cancer patients. Methods: Five hundred and thirty patients who underwent both $^{18}F$-FDG PET/CT and bone scintigraphy within 1 month were retrospectively analyzed. The skeletal system was classified into 10 anatomic segments and interpreted blindly and separately. For each modality, the sensitivity, specificity, accuracy, PPV and NPV were calculated and the results were statistically analyzed. Results: Bone metastases were confirmed in 117 patients with 459 positive segments. On patient-based analysis, the sensitivity, specificity, accuracy, PPV and NPV of $^{18}F$-FDG PET/CT were significantly higher than bone scintigraphy, CT and $^{18}F$-FDG PET (P<0.05). On segment-based analysis, the sensitivity of CT, bone scintigraphy, $^{18}F$-FDG PET and $^{18}F$-FDG PET/CT were 70.4%, 89.5%, 89.1% and 97.8%, respectively (P<0.05, compared with $^{18}F$-FDG PET/CT). The overall specificity and accuracy of the four modalities were 89.1%, 91.8%, 90.3%, 98.2% and 90.3%, 90.9%, 89.8%, 98.0%, respectively (P<0.05, compared with $^{18}F$-FDG PET/CT). The PPV and NPV were 89.8%, 87.6%, 85.6%, 97.2% and 85.6%, 93.2%, 92.8%, 98.6%, respectively. Three hundred and twelve lesions or segments were presented as lytic or sclerotic changes on CT images at the corresponding sites of increased $^{18}F$-FDG uptake. In lytic or mixed lesions, the sensitivity of $^{18}F$-FDG PET/CT and $^{18}F$-FDG PET were better than bone scintigraphy, while in osteoblastic lesions bone scintigraphy had a similar performance with $^{18}F$-FDG PET/CT but better than $^{18}F$-FDG PET alone. Conclusion: Our data allow the conclusion that $^{18}F$-FDG PET/CT is superior to planar bone scintigraphy, CT or $^{18}F$-FDG PET in detecting bone metastasis. $^{18}F$-FDG PET/CT may enhance our diagnosis of tumor bone metastasis and provide more information for cancer treatment.

• Maxillofacial Plastic and Reconstructive Surgery
• /
• 제35권5호
• /
• pp.284-293
• /
• 2013

Purpose: For reconstruction of craniomaxillofacial defects caused by tumor, trauma, infection etc, free flap transplantation with microvascular surgery is a very useful method. Thrombus formation at the anastomosis site is the major cause of graft failure. 4-Hexylresorcinol (4-HR) is generally known as an antiseptic and antiparasitic agent. This study was conducted in order to evaluate the effect of 4-HR on blood coagulation in vitro. In addition, we investigated thrombus formation and endothelial repair of an injured vessel in an animal model. Methods: In the in vitro experiment, we compared blood coagulation time between the 4-HR treated group and normal blood. Thirty rats were used for in vivo animal experiments. After exposure of the right femoral vein, a micro vessel clamp was placed and the femoral vein was intentionally cut. Microvascular anastomosis was performed on all rats using 10-0 nylon under microscopy. The animals were divided into two groups. In the experimental group (n=15), 4-HR (250 mg/kg) mixed with olive oil (10 mL/kg) was administered per os daily. Animals in the control group (n=15) were given olive oil only. The animals were sacrificed at three days, seven days, and fourteen days after surgery and rat femoral vein samples were taken. Vascular patency and thrombus formation were investigated just before sacrifice. Histologic analysis was performed under a microscope. Results: Results of an in vitro blood coagulation test showed that coagulation time was delayed in the 4-HR treated group. The results obtained from an in vivo 4-HR administered rat model showed that the patency of all experimental groups was better at thirty minutes, seven days, and fourteen days after microvascular anastomosis than that of the control group at seven and fourteen days after anastomosis, and the amount of thrombus in the experimental groups was much less than that of the control group. Endothelial repair was observed in the histologic analysis. Conclusion: Findings of this study demonstrated that blood coagulation was delayed in the vitro 4-HR treated group. In addition, good vascular patency, anti-thrombotic effect, and repair of venous endothelial cells were observed in the vivo 4-HR administered rat group.

• Journal of Yeungnam Medical Science
• /
• 제5권1호
• /
• pp.33-42
• /
• 1988

최근 5년간의 소아의 복부종괴 23예를 발생빈도, 부위 및 방사선학적 소견을 중심으로 비교분석하여 다음과 같은 결론을 얻었다. 1. 전체 23예중 신경아세포종이 6예로 가장 많았고 그 다음이 Wilms 종양 5예, 담도낭종, 난소종양, 수신종 등의 순위였다. 2. 발생연령별로 분석해 본 결과 6세 이하가 78%(14예)를 차지했고 특히 후복강 종양은 6세 이하에 집중되어 있었다. 3. 부위별로는 후복강 종양이 60%(14예)로 가장 많았다. 4. 방사선학적 소견을 분석하여 본 결과 1) 단순 복부촬영상 신경아세포종의 50%에서 특징적인 석회와 음영을 볼 수 있었고 후복강 종양의 대부분에서 비특이적인 석회화 음영을 볼 수 있었다. 2) 초음파 소견상 저에코, 고에코 또는 혼합에코 등의 종괴 내부성상을 알 수 있었으나 종괴의 정확한 해부학적 위치를 파악할 수 없는 경우가 많았다. 3) 경정맥 신우 조영촬영상 신우신배의 비정상적인 소견과 신장의 전위 소견으로부터 신장내 종양과 신장의 다른 부위의 종양을 구분할 수 있었다. 4) 전산화 단층촬영상 종괴 내부의 성상뿐만 아니라 종괴의 해부학적인 위치, 주위 구조와의 관계, 임파절이나 다른 부위로의 전이유무를 알 수 있었다.

• Journal of Acupuncture Research
• /
• 제29권1호
• /
• pp.103-113
• /
• 2012

Objectives : The purpose of this study is to evaluate effect of suppressing the expression of cyclo-oxygenase-type-2 (COX-2) as a consequence of inhibition macrophage migration inhibitory factor (MIF) activation by $Sambucus$ $williamsii$ $Hance$ (SWH) pharmacopunctureon rheumatoid arthritis (RA). Methods : In vitro test, synoviocytes extracted from type II collagen-induced arthritis (CIA) mouse's knee joint were cultivated After that, each well of synoviocytes was mixed with the extract of SWH at the dosage of $0.4mg/m{\ell}$, $0.6mg/m{\ell}$, $0.8mg/m{\ell}$, and $1.0mg/m{\ell}$ respectively, and cultivated for 24 hours after the addition. Reverse transcriptase - polymerase chain reaction (RT-PCR) is used to investigate the expression of MIF, Tumor necrosis factor (TNF)-${\alpha}$, COX-2 mRNA. $In$ $vivo$ test, thirty DBA female mice were used, and each ten mice were allocated into three group; normal group, CIA-elicitated group, and group treated with SWH pharmacopuncture on it's the point of $ST_{35}$ after CIA elicitation. It is investigated that change of mice foot thickness, histologic change of sliced synovial joint of mouse, and extent change of MIF, TNF-${\alpha}$, COX-2 in synovial membrane. Results : $In$ $vitro$ test, the expressions of cytokine(MIF, TNF-${\alpha}$, COX-2) mRNAs related to RA were dose-dependent decreased. In the SWH pharmacopuncture group, foot thickness and histologic change of sliced synovial joint were decreased comparing with CIA-elicitated group's change. In the SWH pharmacopuncture group, the suppression of MIF, TNF-${\alpha}$, COX-2 in synovial membrane was clearly shown comparing with CIA-elicitated group's change. Conclusions : It might be suggested that SWH pharmacopuncture mitigate tissue damage originated from rheumatoid arthritis by suppressing the expression of COX-2 as a consequence of inhibition MIF activation.